Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “Enanta Pharmaceuticals, Inc.”

218 pharma patents match "Enanta Pharmaceuticals, Inc." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 218
Index total 30,257
Page 3 / 10

Quick answer

This filtered view shows 218 pharmaceutical patents matching "Enanta Pharmaceuticals, Inc." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

218 results for “Enanta Pharmaceuticals, Inc.” · 30,257 patents in full index Clear search

  1. US 10968249

    Bile acid derivatives as FXR/TGR5 agonists and methods of use thereof

    Enanta Pharmaceuticals, Inc. · Granted Apr 6, 2021 · Expires Apr 1, 2041

    granted

  2. US 10952978

    Hepatitis B antiviral agents

    Enanta Pharmaceuticals, Inc. · Granted Mar 23, 2021 · Expires Mar 18, 2041

    granted

  3. US 10934306

    Hepatitis B antiviral agents

    Enanta Pharmaceuticals, Inc. · Granted Mar 2, 2021 · Expires Feb 25, 2041

    granted

  4. US 10881666

    Combination pharmaceutical agents as RSV inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Jan 5, 2021 · Expires Dec 31, 2040

    granted

  5. US 10865215

    Benzodiazepine derivatives as RSV inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Dec 15, 2020 · Expires Dec 10, 2040

    granted

  6. US 10865211

    Functionalized heterocycles as antiviral agents

    Enanta Pharmaceuticals, Inc. · Granted Dec 15, 2020 · Expires Dec 10, 2040

    granted

  7. US 10851115

    Heterocyclic compounds as RSV inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Dec 1, 2020 · Expires Nov 26, 2040

    granted

  8. US 10829486

    Isoxazole derivatives as FXR agonists and methods of use thereof

    Enanta Pharmaceuticals, Inc. · Granted Nov 10, 2020 · Expires Nov 5, 2040

    granted

  9. US 10759816

    Heterocyclic compounds as RSV inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Sep 1, 2020 · Expires Aug 27, 2040

    granted

  10. US 10752598

    Aryldiazepine derivatives as RSV inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Aug 25, 2020 · Expires Aug 20, 2040

    granted

  11. US 10738035

    Hepatitis B antiviral agents

    Enanta Pharmaceuticals, Inc. · Granted Aug 11, 2020 · Expires Aug 6, 2040

    granted

  12. US 10729688

    Hepatitis B antiviral agents

    Enanta Pharmaceuticals, Inc. · Granted Aug 4, 2020 · Expires Jul 30, 2040

    granted

  13. US 10723733

    Hepatitis B antiviral agents

    Enanta Pharmaceuticals, Inc. · Granted Jul 28, 2020 · Expires Jul 23, 2040

    granted

  14. US 10702528

    Hepatitis B antiviral agents

    Enanta Pharmaceuticals, Inc. · Granted Jul 7, 2020 · Expires Jul 2, 2040

    granted

  15. US 10696713

    Bile acid derivatives as FXR/TGR5 agonists and methods of use thereof

    Enanta Pharmaceuticals, Inc. · Granted Jun 30, 2020 · Expires Jun 25, 2040

    granted

  16. US 10683279

    Apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof

    Enanta Pharmaceuticals, Inc. · Granted Jun 16, 2020 · Expires Jun 11, 2040

    granted

  17. US 10647711

    Azepin-2-one derivatives as RSV inhibitors

    Enanta Pharmaceuticals, Inc. · Granted May 12, 2020 · Expires May 7, 2040

    granted

  18. US 10640511

    Hepatitis B antiviral agents

    Enanta Pharmaceuticals, Inc. · Granted May 5, 2020 · Expires Apr 30, 2040

    granted

  19. US 10597382

    Tetrazole containing apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof

    Enanta Pharmaceuticals, Inc. · Granted Mar 24, 2020 · Expires Mar 19, 2040

    granted

  20. US 10597391

    Urea-containing isoxazole derivatives as FXR agonists and methods of use thereof

    Enanta Pharmaceuticals, Inc. · Granted Mar 24, 2020 · Expires Mar 19, 2040

    granted

  21. US 10570153

    Benzodiazepine derivatives as RSV inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Feb 25, 2020 · Expires Feb 20, 2040

    granted

  22. US 10538532

    Hepatitis B antiviral agents

    Enanta Pharmaceuticals, Inc. · Granted Jan 21, 2020 · Expires Jan 16, 2040

    granted

  23. US 10519191

    Bile acid analogs as FXR/TGR5 agonists and methods of use thereof

    Enanta Pharmaceuticals, Inc. · Granted Dec 31, 2019 · Expires Dec 26, 2039

    granted

  24. US 10472386

    Bile acid derivatives as FXR agonists and methods of use thereof

    Enanta Pharmaceuticals, Inc. · Granted Nov 12, 2019 · Expires Nov 7, 2039

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.